Ursprung des Netzwerks ersten Grades von Niamh Alix

EinheitArt der EinheitIndustrie
Public Company Biotechnology 20
Subsidiary Pharmaceuticals: Major 7

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Niamh Alix

UnternehmenSektorVerknüpfte PersonenHauptposition
AMGEN INC. Pharmaceuticals: Major

Michael Kelly

Ran Zheng

Director of Finance/CFO

Corporate Officer/Principal

Biotechnology

David Schenkein

Ann Lee

Corporate Officer/Principal

Corporate Officer/Principal

BIOGEN INC. Pharmaceuticals: Major

Michael Kelly

Richard Brudnick

Jeremy Duffield

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Kaye Foster-Cheek

Robert Nelsen

David Schenkein

John Evans

Private Equity Investor

Founder

Private Equity Investor

Private Equity Investor

IRONWOOD PHARMACEUTICALS, INC. Pharmaceuticals: Major

Stephen Knight

Karen Brown

Director/Board Member

Corporate Officer/Principal

TENGION, INC. Biotechnology

Jeffrey D. Marrazzo

Corporate Officer/Principal

Miscellaneous Commercial Services

David Schenkein

Jeffrey D. Marrazzo

Director/Board Member

Director/Board Member

MOLMED S.P.A. Pharmaceuticals: Major

Fulvio Mavilio

Corporate Officer/Principal

AGIOS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Kaye Foster-Cheek

Robert Nelsen

David Schenkein

John Evans

Carman Alenson

Meredith Goldwasser

Director/Board Member

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Comptroller/Controller/Auditor

Corporate Officer/Principal

The Trustees of Columbia University in The City of New York College/University

Stephen Knight

Keith Gottesdiener

Mohammed Asmal

Wendy Chung

Undergraduate Degree

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

College/University

Jeffrey D. Marrazzo

Mohammed Asmal

Meredith Goldwasser

Graduate Degree

Undergraduate Degree

Undergraduate Degree

University of Pennsylvania College/University

Keith Gottesdiener

John Evans

Jeffrey D. Marrazzo

Meredith Goldwasser

Doctorate Degree

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Boston University College/University

Carman Alenson

Karen Brown

Masters Business Admin

Doctorate Degree

BLUEBIRD BIO, INC. Biotechnology

David Schenkein

Mohammed Asmal

Director/Board Member

Chief Tech/Sci/R&D Officer

Yale University College/University

John Evans

Ann Lee

Undergraduate Degree

Doctorate Degree

College/University

Ann Lee

Wendy Chung

Undergraduate Degree

Undergraduate Degree

Medical Specialties

Anne Dupraz-Poiseau

Corporate Officer/Principal

Freie Universität Berlin College/University

Anne Dupraz-Poiseau

Doctorate Degree

Pharmaceuticals: Major

Keith Gottesdiener

Ann Lee

Corporate Officer/Principal

Corporate Officer/Principal

European Molecular Biology Organization

Fulvio Mavilio

Corporate Officer/Principal

Investment Managers

David Schenkein

Private Equity Investor

Università degli Studi di Modena e Reggio Emilia College/University

Fulvio Mavilio

Corporate Officer/Principal

Università degli Studi di Roma Tor Vergata College/University

Fulvio Mavilio

Undergraduate Degree

Biotechnology

Fulvio Mavilio

Chief Tech/Sci/R&D Officer

BLUEPRINT MEDICINES CORPORATION Biotechnology

Stephen Knight

David Schenkein

Director/Board Member

Director/Board Member

Packaged Software

Jeffrey D. Marrazzo

Corporate Officer/Principal

AUDENTES THERAPEUTICS, INC. Biotechnology

Fulvio Mavilio

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

John Evans

Jeffrey D. Marrazzo

Masters Business Admin

Masters Business Admin

JUNO THERAPEUTICS INC Biotechnology

Robert Nelsen

Ann Lee

Founder

Chief Tech/Sci/R&D Officer

SPARK THERAPEUTICS, INC. Biotechnology

Jeffrey D. Marrazzo

Founder

Columbia University College of Physicians & Surgeons College/University

Keith Gottesdiener

Corporate Officer/Principal

Miscellaneous Commercial Services

Anne Dupraz-Poiseau

Corporate Officer/Principal

San Raffaele-Telethon Institute for Gene Therapy

Fulvio Mavilio

Director/Board Member

PIERIS PHARMACEUTICALS, INC. Biotechnology

Allan Reine

Director of Finance/CFO

Miscellaneous Commercial Services

Fulvio Mavilio

Director/Board Member

DENALI THERAPEUTICS INC. Biotechnology

Robert Nelsen

Stephen Knight

David Schenkein

Director/Board Member

Director/Board Member

Director/Board Member

Medical Specialties

Kaye Foster-Cheek

Robert Nelsen

Director/Board Member

Director/Board Member

BEAM THERAPEUTICS INC. Biotechnology

Robert Nelsen

Stephen Knight

John Evans

Director/Board Member

Director/Board Member

Chief Executive Officer

University of Dental Surgery College/University

Anne Dupraz-Poiseau

Doctorate Degree

University of Medicine College/University

Anne Dupraz-Poiseau

Doctorate Degree

Meditest Internacional

Anne Dupraz-Poiseau

Founder

SANA BIOTECHNOLOGY, INC. Biotechnology

Robert Nelsen

Stephen Knight

Founder

Director/Board Member

Biotechnology

Fulvio Mavilio

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Kaye Foster-Cheek

Robert Nelsen

Director/Board Member

Chairman

Miscellaneous Commercial Services

Stephen Knight

David Schenkein

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Michael Kelly

Jeffrey D. Marrazzo

Thomas Cahill

Director/Board Member

Director/Board Member

Director/Board Member

Biotechnology

John Evans

Director/Board Member

Packaged Software

Robert Nelsen

Stephen Knight

Director/Board Member

Director/Board Member

Statistik

International

Vereinigte Staaten 38
Italien 5
Frankreich 4
Deutschland 3
Niederlande 3

Sektoral

Health Technology 24
Consumer Services 14
Commercial Services 7
Finance 3
Technology Services 3

Operativ

Director/Board Member 172
Corporate Officer/Principal 55
Independent Dir/Board Member 43
Undergraduate Degree 23
Doctorate Degree 19
  1. Börse
  2. Insiders
  3. Niamh Alix
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT